List of Excipients in API ALOSETRON HYDROCHLORIDE
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing ALOSETRON HYDROCHLORIDE
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Actavis Pharma Inc | ALOSETRON HYDROCHLORIDE | alosetron hydrochloride | 45963-479 | CELLULOSE, MICROCRYSTALLINE | |
| Actavis Pharma Inc | ALOSETRON HYDROCHLORIDE | alosetron hydrochloride | 45963-479 | HYPROMELLOSES | |
| Actavis Pharma Inc | ALOSETRON HYDROCHLORIDE | alosetron hydrochloride | 45963-479 | LACTOSE | |
| Actavis Pharma Inc | ALOSETRON HYDROCHLORIDE | alosetron hydrochloride | 45963-479 | MAGNESIUM STEARATE | |
| Actavis Pharma Inc | ALOSETRON HYDROCHLORIDE | alosetron hydrochloride | 45963-479 | STARCH, CORN | |
| Actavis Pharma Inc | ALOSETRON HYDROCHLORIDE | alosetron hydrochloride | 45963-479 | TITANIUM DIOXIDE | |
| Actavis Pharma Inc | ALOSETRON HYDROCHLORIDE | alosetron hydrochloride | 45963-479 | TRIACETIN | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing ALOSETRON HYDROCHLORIDE
Detailed excipient profiles for ALOSETRON HYDROCHLORIDE
Excipient focus: ANHYDROUS LACTOSE
ALOSETRON HYDROCHLORIDE drug variants containing ANHYDROUS LACTOSE
| Company | Ingredient | NDC |
|---|---|---|
| West-Ward Pharmaceuticals Corp | alosetron hydrochloride | 0054-0295 |
| >Company | >Ingredient | >NDC |
ALOSETRON HYDROCHLORIDE drug variants not containing ANHYDROUS LACTOSE
Excipient focus: CELLULOSE, MICROCRYSTALLINE
ALOSETRON HYDROCHLORIDE drug variants containing CELLULOSE, MICROCRYSTALLINE
ALOSETRON HYDROCHLORIDE drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE 2910
ALOSETRON HYDROCHLORIDE drug variants containing HYPROMELLOSE 2910
| Company | Ingredient | NDC |
|---|---|---|
| Par Pharmaceutical Inc | alosetron hydrochloride | 49884-819 |
| Rising Pharmaceuticals Inc | alosetron hydrochloride | 64980-453 |
| >Company | >Ingredient | >NDC |
ALOSETRON HYDROCHLORIDE drug variants not containing HYPROMELLOSE 2910
Excipient focus: HYPROMELLOSES
ALOSETRON HYDROCHLORIDE drug variants containing HYPROMELLOSES
ALOSETRON HYDROCHLORIDE drug variants not containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| West-Ward Pharmaceuticals Corp | alosetron hydrochloride | 0054-0295 |
| Par Pharmaceutical Inc | alosetron hydrochloride | 49884-819 |
| Rising Pharmaceuticals Inc | alosetron hydrochloride | 64980-453 |
| >Company | >Ingredient | >NDC |
Excipient focus: LACTOSE
ALOSETRON HYDROCHLORIDE drug variants containing LACTOSE
ALOSETRON HYDROCHLORIDE drug variants not containing LACTOSE
| Company | Ingredient | NDC |
|---|---|---|
| West-Ward Pharmaceuticals Corp | alosetron hydrochloride | 0054-0295 |
| Amneal Pharmaceuticals of New York LLC | alosetron hydrochloride | 53746-248 |
| Amneal Pharmaceuticals LLC | alosetron hydrochloride | 65162-248 |
| >Company | >Ingredient | >NDC |
Excipient focus: LACTOSE MONOHYDRATE
ALOSETRON HYDROCHLORIDE drug variants containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Amneal Pharmaceuticals of New York LLC | alosetron hydrochloride | 53746-248 |
| Amneal Pharmaceuticals LLC | alosetron hydrochloride | 65162-248 |
| >Company | >Ingredient | >NDC |
ALOSETRON HYDROCHLORIDE drug variants not containing LACTOSE MONOHYDRATE
Excipient focus: MAGNESIUM STEARATE
ALOSETRON HYDROCHLORIDE drug variants containing MAGNESIUM STEARATE
ALOSETRON HYDROCHLORIDE drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL
ALOSETRON HYDROCHLORIDE drug variants containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Amneal Pharmaceuticals of New York LLC | alosetron hydrochloride | 53746-248 |
| Amneal Pharmaceuticals LLC | alosetron hydrochloride | 65162-248 |
| >Company | >Ingredient | >NDC |
ALOSETRON HYDROCHLORIDE drug variants not containing POLYETHYLENE GLYCOL
Excipient focus: POLYSORBATE 80
ALOSETRON HYDROCHLORIDE drug variants containing POLYSORBATE 80
| Company | Ingredient | NDC |
|---|---|---|
| Amneal Pharmaceuticals of New York LLC | alosetron hydrochloride | 53746-248 |
| Amneal Pharmaceuticals LLC | alosetron hydrochloride | 65162-248 |
| >Company | >Ingredient | >NDC |
ALOSETRON HYDROCHLORIDE drug variants not containing POLYSORBATE 80
Excipient focus: STARCH, CORN
ALOSETRON HYDROCHLORIDE drug variants containing STARCH, CORN
ALOSETRON HYDROCHLORIDE drug variants not containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
ALOSETRON HYDROCHLORIDE drug variants containing TITANIUM DIOXIDE
ALOSETRON HYDROCHLORIDE drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| West-Ward Pharmaceuticals Corp | alosetron hydrochloride | 0054-0295 |
| >Company | >Ingredient | >NDC |
Excipient focus: TRIACETIN
ALOSETRON HYDROCHLORIDE drug variants containing TRIACETIN
ALOSETRON HYDROCHLORIDE drug variants not containing TRIACETIN
| Company | Ingredient | NDC |
|---|---|---|
| West-Ward Pharmaceuticals Corp | alosetron hydrochloride | 0054-0295 |
| Amneal Pharmaceuticals of New York LLC | alosetron hydrochloride | 53746-248 |
| Amneal Pharmaceuticals LLC | alosetron hydrochloride | 65162-248 |
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
